Targeting Histone Deacetylases to Modulate Graft-Versus-Host Disease and Graft-Versus-Leukemia

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the main therapeutic strategy for patients with both malignant and nonmalignant disorders. The therapeutic benefits of allo-HSCT in malignant disorders are primarily derived from the graft-versus-leukemia (GvL) effect, in which T cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sena, Santhanam, Srikanth, Lim, Sora, Choi, Jaebok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349873/
https://www.ncbi.nlm.nih.gov/pubmed/32560120
http://dx.doi.org/10.3390/ijms21124281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349873/
https://www.ncbi.nlm.nih.gov/pubmed/32560120
http://dx.doi.org/10.3390/ijms21124281

Ejemplares similares